Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer

NCT00956280 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00956280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00956280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
April 30, 2010
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer